Hemophilia Treatment Drugs Market by Product Type (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrates, Desmopressin, and Antifibrinolytic Agents), by Disease Type (Hemophilia A, Hemophilia B, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-Commerce) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Global hemophilia treatment drugs market expected to generate revenue of around USD 25.61 billion by the end of 2024, growing at a CAGR of around 5.7% between 2017 and 2024. Hemophilia is a genetic disorder in which the blood clotting factors are reduced; this hampers the function of blood clotting and leads to abnormal internal and external bleeding after any type of injuries.

04-Jul-2018 | Number of pages: 110 | Report Code: ZMR-3187 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the hemophilia treatment drugs market on a global and regional level. The study provides historical data from 2015 to 2017 along with the forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the hemophilia treatment drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hemophilia treatment drugs market on a global level.

In order to give the users of this report a comprehensive view on the hemophilia treatment drugs market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Hemophilia Treatment Drugs Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product and regional expansion of major participants involved in the market.

The study provides a decisive view on the hemophilia treatment drugs market by segmenting it on the basis of product type, disease type, distribution channel, and region. All the segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further categorization into major countries including the U.S., the UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for hemophilia treatment drugs market based on all segments in all the regions and countries.

The report also includes detailed profiles of end players such as Shire Plc., Novo Nordisk A/S, Pfizer, Bayer AG, CSL Ltd., Biogen, and others.

This report segments the global hemophilia treatment drugs market as follows:

Global Hemophilia Treatment Drugs Market: Product Type Segment Analysis

  • Recombinant Coagulation Factor Concentrates
  • Plasma Derived Coagulation Factor Concentrates
  • Desmopressin
  • Antifibrinolytic Agents

Global Hemophilia Treatment Drugs Market: Disease Type Segment Analysis

  • Hemophilia A
  • Hemophilia B
  • Others

Global Hemophilia Treatment Drugs Market: Distribution Channel Segment Analysis

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

Global Hemophilia Treatment Drugs Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Diagnostic Specialty Enzyme Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3628 | Report Format:

Global Diagnostic Specialty Enzymes Market: Overview Diagnostic specialty enzymes find applications in low volume and high value-added applications. Major use of diagnostic specialty enzymes is in clinical chemistry, molecular diagnostics, and immunoassay. They help in reduction of systemic infl...Read More

Calcitriol Market by Product Type (Calcitriol Capsule, Calcitriol Solution, and Others), by Application (Osteoporosis, Renal Osteodystrophy, and Others), and by Distribution Channel (Direct Sales and Distributor): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Dec-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3601 | Report Format:

The report covers a forecast and an analysis for the Calcitriol Market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the Calcitriol market along...Read More

Plant Sterol Esters Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3522 | Report Format:

Global Plant Sterol Esters Market: Overview Sterol esters are the heterogeneous chemical composites that are found in tiny proportions in eachcell type. These compounds are produced when sterol and fatty acids are esterified. Furthermore, plant sterols, which are found in fatty tissues of plants...Read More

Pharmaceutical Intermediates Market by Product Type (GMP and Non GMP), by Applications (Antibiotics, Antipyretic analgesics, Vitamins, and Others), and by Distribution Channel (Direct Sales and Distributor): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3440 | Report Format:

The report covers forecast and analysis for the pharmaceutical intermediates market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pharmac...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.